During the past decade, Hospital Italiano de La Plata conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 23 clinical trials were completed, i.e. on average, 62.2% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 21 clinical trials were completed. i.e. 123.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Italiano de La Plata" #1 sponsor was "Janssen Research & Development, LLC" with 13 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Genentech, Inc." with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Italiano de La Plata" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Italiano de La Plata" are "Heart Failure" (3 trials), "Respiratory Syncytial Virus Infections" (3 trials), "Chronic Myeloid Leukemia" (2 trials), "Colitis, Ulcerative" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Hospital Italiano de La Plata" in a lesser frequency.

Most popular intervention types in "Hospital Italiano de La Plata" are "Drug" (39 trials), "Other" (9 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "GDC-0853" (3 trials), "Empagliflozin" (2 trials), "Pimodivir 600 mg" (2 trials) and "SOC Treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Italiano de La Plata" are 44 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Italiano de La Plata". undefined are not yet recruiting, 10 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Hospital Italiano de La Plata, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Italiano de La Plata, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".